• 首页期刊简介编委会刊物订阅专栏专刊电子刊广告合作联系我们English
引用本文:陈泳霖,张文君,张国锋,李想,吴梦婷.川芎嗪治疗心脑血管疾病的纳米载药系统的研究进展[J].中国现代应用药学,2022,39(22):3038-3044.
CHEN Yonglin,ZHANG Wenjun,ZHANG Guofeng,LI Xiang,WU Mengting.Research progress of tetramethylpyrazine in the treatment of cardiovascular and cerebrovascular diseases with nano drug delivery system[J].Chin J Mod Appl Pharm(中国现代应用药学),2022,39(22):3038-3044.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 920次   下载 475 本文二维码信息
码上扫一扫!
分享到: 微信 更多
川芎嗪治疗心脑血管疾病的纳米载药系统的研究进展
陈泳霖1, 张文君1, 张国锋2, 李想1, 吴梦婷1
1.哈尔滨商业大学药学院, 哈尔滨 150076;2.黑龙江农业工程职业学院, 哈尔滨 150025
摘要:
川芎嗪(tetramethylpyrazine,TMP)是从传统中药川芎中提取的生物碱单体,具有广泛的药理活性,尤其在治疗高血压、冠心病等心血管疾病方面受到广泛的关注。但由于TMP的不稳定性和生物利用度较差、代谢快且半衰期短等问题,在一定程度上限制了其在临床上的广泛应用,应用纳米载药系统可解决这一问题。本文主要对TMP治疗心脑血管疾病的药理作用及其应用纳米载药系统治疗心脑血管疾病的研究进展进行综述,以期为TMP的进一步开发研究提供参考。
关键词:  川芎嗪|心脑血管疾病|纳米载药系统
DOI:10.13748/j.cnki.issn1007-7693.2022.22.021
分类号:R283.6
基金项目:
Research progress of tetramethylpyrazine in the treatment of cardiovascular and cerebrovascular diseases with nano drug delivery system
CHEN Yonglin1, ZHANG Wenjun1, ZHANG Guofeng2, LI Xiang1, WU Mengting1
1.School of Pharmaceutical Science, Harbin University of Commerce, Harbin 150076, China;2.Heilongjiang Agricultural Engineering Vocational College, Harbin 150025, China
Abstract:
Tetramethylpyrazine(TMP) is an alkaloid monomer extracted from the traditional Chinese medicine Chuanxiong Rhizoma. It has a wide range of pharmacological activities, especially in the treatment of hypertension, coronary heart disease and other cardiovascular diseases. However, due to the poor volatility and bioavailability of TMP, fast metabolism and short half-life, to a certain extent, it has limited its widely clinical application. The application of nano drug delivery system can solve this problem. This article mainly reviewed the pharmacological effects of TMP in the treatment of cardiovascular and cerebrovascular diseases and the research progress of the application of nanometer drug delivery system in the treatment of cardiovascular and cerebrovascular diseases, in order to provide a reference for the further development and research of TMP.
Key words:  tetramethylpyrazine|cardio-cerebrovascular disease|nano drug delivery system
扫一扫关注本刊微信